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Background-—We evaluated the relationship of aortic root dimension (ARD) with ﬂow output and both peripheral and central blood
pressure, using multivariable equations predicting ideal sex-speciﬁc ARD at a given age and body height.
Methods and Results-—We measured echocardiographic diastolic ARD at the sinuses of Valsalva in 3160 adults (aged
4216 years, 61% women) from the fourth examination of the Strong Heart Study who were free of prevalent coronary heart
disease, and we compared measured data with the theoretical predicted value to calculate a z score. Central blood pressure was
estimated by applanation tonometry of the radial artery in 2319 participants. ARD z scores were divided into tertiles representing
small, normal, and large ARD. Participants with large ARD exhibited greater prevalence of central obesity and higher levels of
inﬂammatory markers and lipids (0.05<P<0.0001). Stroke volume, heart rate, and both cuff and central diastolic blood pressure
were progressively greater from small to large ARD (all P<0.0001). Pulse pressure was higher in small ARD (P<0.0001). In
multivariable analysis, ARD z score was related positively to stroke volume, either cuff or central diastolic blood pressure, and
negatively to pulse pressure. Large ARD was also independently correlated to higher waist circumference and percentages of
neutrophils and plasminogen activator inhibitor-1 (all P<0.01).
Conclusions-—Aortic root dilatation is associated with high diastolic blood pressure, high stroke volume, central fat distribution,
and inﬂammatory status. In contrast, at a given diastolic blood pressure and stroke volume, aortic root dilatation is associated with
lower pulse pressure and systolic blood pressure. ( J Am Heart Assoc. 2015;4:e002309 doi: 10.1161/JAHA.115.002309)
Key Words: aortic root dilatation • applanation tonometry • blood pressure • inﬂammation • neutrophil count • pulse
pressure • stroke volume
A ortic root (AR) dilatation has been associated with aorticregurgitation, hypertension, arteriosclerosis, and hyper-
tensive end-organ damage, including increased peripheral
resistance, carotid intima–media thickness, and evidence of
plaque.1–5 Although there is evidence of the relationship
between AR dimension (ARD) and peripheral resistance,2
there are inconsistent ﬁndings regarding the relationship
with components of blood pressure (BP). In clinical and
epidemiologic settings, ARD is generally associated posi-
tively with diastolic BP but negatively with pulse pressure
(PP) and systolic BP,6,7 measured with cuff sphygmo-
manometry.
The effects of BP components and hemodynamics on the
variance of ARD remain uncertain, given the difﬁculty of
identifying a clear cause–effect relationship and the lack of
data on the relationship between ARD and central BP. In
addition, relationships between BP and ARD vary according to
the level at which ARD is measured, namely, sinuses of
Valsalva versus ascending aorta.8 Consequently, the nature of
the association between hypertension and AR dilatation still
needs to be clariﬁed.1,6,8–10 This uncertainty makes these
relationships similar to a “chicken and egg” question.
The physiological interaction between ARD and components
of BP is regulated by key factors, including demographic,
hemodynamic, and biological determinants. A number of
previous reports strongly suggest that age, sex, and body size
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are the most relevant variables to be considered when
estimating whether or not AR is dilated.6,9,11–14 Analyses
taking into account the effect of these potent determinants
might contribute to clariﬁcation of the interplay among ARD,
components of BP, and ﬂow output, a potential component of
ARD variance that has been neglected. To isolate the effect
of demographics and anthropometrics on the variability of
ARD, we previously analyzed ARD in 1207 multiethnic,
nonobese, normotensive, nondiabetic participants who
were free of cardiovascular (CV) disease or aortic valve
disease11 to generate multivariable equations and nomograms
to predict the ideal sex-speciﬁc ARD at a given age and body
size.
In the present project, we applied these equations to
participants in the fourth examination of the Strong Heart
Study to evaluate the relationship of differences between
actual ARD and the theoretical predictions for age, sex, and
body size with both peripheral and central BP components.
We also considered the impact of ﬂow output and other
potentially important biological parameters.
Methods
Study Population
Initiated as a longitudinal population-based survey of CV risk
factors and CV disease in American Indians from 13
communities in Arizona, Oklahoma, and South and North
Dakotas,14–17 the Strong Heart Study was extended to
members of large 3-generation families (Strong Heart Family
Study) during the fourth phase (between 2001 and 2003).15,16
From the fourth examination Strong Heart Study cohort of
3642 participants, we excluded 27 participants with coronary
heart disease, 14 participants with aortic stenosis or regur-
gitation, and 9 with more than mild mitral regurgitation. From
the remaining 3592 participants who were free of CV disease,
3251 were aged >17 years, and 3160 (97%) of those had
available echocardiographic measurement of ARD and were
included in the analysis. Participants gave written informed
consent under protocols approved by all participating com-
munities and institutional review boards.
Laboratory Tests and Deﬁnitions
Fasting plasma glucose was measured by standard methods.
Diabetes (fasting glucose ≥126 mg/dL or ongoing antidia-
betic treatment) was diagnosed based on 1997 American
Diabetes Association recommendations. Obesity was classi-
ﬁed based on the 1998 National Institutes of Health
guidelines (body mass index ≥30 kg/m2). Waist circumfer-
ence was used as a measure of central fat distribution.
Hypertension was deﬁned by the Seventh Report of the Joint
National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure criteria (BP ≥140/
90 mm Hg or use of antihypertensive treatment). C-reactive
protein, plasminogen activator inhibitor-1, ﬁbrinogen, and
white cell count were measured by standard methods.
Fat-free mass and adipose body mass were estimated by
using an RJL bioelectric impedance meter (model B14101; RJL
Equipment Co). Equations for estimating fat-free mass in
kilograms based on total body water, using bioelectric
resistance, had been validated previously in the American
Indian population.17 Adipose mass was estimated by
subtracting fat-free mass from body weight. BP was recorded
according to the procedures reported in the study opera-
tion manuals (http://strongheart.ouhsc.edu/manual/Pha-
seIV/Volume3.pdf) and in pilot manuscripts,18,19 with the
participant sitting with the right arm on table and using a
standard manometer. After 5 minutes of resting, the cuff was
inﬂated to >30 mm Hg above the obliteration pressure, held
constant for 5 seconds, and then slowly deﬂated (2 mm/s)
while reading pressures for ﬁrst and ﬁfth Korotkoff phases.
Before the second and third measurements, participants were
requested to raise the arm for 5 seconds. After another
25 seconds with the arm on the table, the measurement was
repeated for the second and third times. The average of the
last 2 measurements was used for analysis. Cuff was
determined based on the arm circumference, taken with
participants sitting with the right arm hanging freely, with
the right hand resting on the right knee, and with the tape
measure placed horizontally at the midpoint between the
acromion and olecranon. Results of arm circumference were
rounded to the nearest centimeter.
Echocardiography
Echocardiograms were performed using phased-array com-
mercial echocardiographs with M-mode, 2-dimensional, and
Doppler capabilities, as reported previously.18 Left ventricular
dimensions and septal and posterior left ventricular wall
thicknesses were measured based on American Society of
Echocardiography recommendations.19,20 Left ventricular vol-
umes were estimated from linear dimensions by the z-derived
method21 and used to derive stroke volume. An estimate of
arterial compliance was also generated by the ratio of stroke
volume to PP.
Echocardiographic ARD was measured at the sinuses of
Valsalva during diastole, by the leading edge-to-leading edge
method.9 The raw measure of ARD was compared with the
value predicted for age, sex, and body size, using an equation
previously generated in a large multiethnic population of
healthy persons.11 This approach has been validated recently
in a population of patients with Marfan syndrome.22 Due to
the high prevalence of obesity in the Strong Heart Study
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population, we used height as the measure of body size in the
following equation (ARDpred indicates predicted ARD):
ARDpredðhtÞ ¼ 1:52þ ðageyrs  0:01Þ þ ðHeightcm  0:01Þ
 ðsex1¼M;2¼F  0:25Þ
A sex-speciﬁc z score was calculated by the individual
difference between measured ARD and predicted ARD values,
divided by the sex-speciﬁc standard deviation of measured
ARD in the present population (ARD-z). Consequently, positive
values of ARD-z identiﬁed higher-than-predicted ARD, whereas
negative values indicated ARD smaller than those predicted
by age, sex, and body size. Cuff BP measured at the end of the
echocardiogram by an aneroid sphygmomanometer was used
for analysis in this study.
The reliability of our echocardiographic measurements was
analyzed previously in a large population sample from a
clinical trial.23
Carotid Ultrasonography and Applanation
Tonometry
Carotid ultrasound was performed using a standardized
protocol24 and commercial machines. The protocol has been
reported extensively.25 Brieﬂy, ECG-gated 2-dimensionally
guided M-mode tracings of the distal common carotid artery
1 cm proximal to the carotid bulb were obtained and read
ofﬂine by an experienced cardiologist. Following calibration
for depth and time, the end-diastolic wall thickness (combined
intima–media thickness of the far wall) and end-diastolic and
peak-systolic internal diameters (by continuous tracing of the
lumen–intima interface of the near and far walls) were
measured on several cycles using electronic calipers and
averaged. Carotid plaque was rare in this relatively young
population and was not analyzed.
As reported previously,26 radial arterial pressure waveforms
were obtained by applanation tonometry (SphygmoCor Sys-
tem) in 2319 adult participants from the Oklahoma and South
and North Dakota ﬁeld centers who were free of prevalent CV
disease (73%) to generate estimates of central systolic and
diastolic BP. Applanation tonometry has been validated to
yield accurate estimates of intra-arterial pressure.27 Brachial
systolic and diastolic pressures for calibration were entered by
averaging the last 2 of 3 sequential brachial pressure readings
made at the end of the echocardiographic procedure (http://
strongheart.ouhsc.edu/manual/PhaseIV/Volume5.pdf).
Statistical Analysis
Analyses were performed to examine the associations of
variability of ARD-z with 4 critical physiological components: (1)
cuff diastolic BP, as the steady stress imposed on the Valsalva
sinuses at the closure of aortic valve; (2) stroke volume, a
measure of left ventricular performance28 that represents the
ﬂow volume distending the proximal aorta during ventricular
contraction; (3) cuff PP, as the measure of the combined left
ventricular ability to expel blood and the aortic capacitance
(systolic BP was also used in alternative analyses); and (4) heart
rate, as the marker of the frequency of the aortic distension per
unit time. In the subpopulation in which applanation tonometry
was available, estimates of central systolic diastolic and pulse
BP were also evaluated in alternative analyses.
Data were analyzed using SPSS 22.0 (IBM Corp) and
expressed as mean1 SD or proportion in the chi-square
distribution. Indicator variables were included for the Arizona,
South and North Dakota, and Oklahoma ﬁeld centers. We
analyzed main biological characteristics in tertiles of ARD-z,
labeled for convenience as small, normal, and large ARD, using
ANOVA and simple main effect with Sidak correction for
identiﬁcation of differences. Tertile allocation was made
automatically by the SPSS package. Multiple linear regression
analysis was used to analyze the variance of ARD-z in relation to
the 4 main components, which we hypothesize contributed
independently to modulation of ARD variance. In a second
model, body composition, markers of inﬂammation, and lipid
proﬁle—identiﬁed as associated with ARD in the exploratory
analyses—were added. Because the level of relatedness was
high in this population, we also adjusted for a standard kinship
coefﬁcient based on the level of relatedness within a family, as
reported previously.29 In the third model, antihypertensive
therapy (classes of medications signiﬁcantly different among
the tertiles of ARD-z) was also forced into the previous model.
Variance inﬂation factor was computed to explore the level of
multicollinearity. The variance inﬂation factor was maintained
within the range considered to be acceptable (ie, <10).30
Although well below 10, the highest level of variance inﬂation
factor was expectedly reached by the combination of fat-free
mass, fat mass, and waist circumference; these 3 parameters
offer a high degree of biological collinenarity. The decision to
maintain all 3 variables in the equation wasmade on the basis of
the different biological meanings of these parameters, with the
ﬁrst 2 being expressions of general body composition and waist
circumference being the marker of speciﬁc abdominal fat
distribution. A 2-tailed P≤0.05 was assumed to be statistically
signiﬁcant.
Results
The mean age of the study population was 4216 years
(range 18 to 93 years), and there was a predominance of
women (61%). In men and women, respectively, arterial
hypertension was present in 40% and 32%, obesity was
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present in 54% and 62% (both P<0.0001), and diabetes was
present in 22% and 25% (P not signiﬁcant).
Figure displays the normal distribution of ARD-z. ARD-z
ranged between 3.75 and 4.04 SD from the mean predicted
values.
Table 1 presents the characteristics associated with
tertiles of ARD-z in the whole study population. Participants
with large ARD were younger than those with small ARD and
exhibited greater prevalence of central obesity, with greater
amounts of body components (both fat and fat-free mass) and
higher levels of inﬂammatory markers and cholesterol
(0.05<P<0.0001). Carotid intima–media complex was thicker
and diastolic diameter was smaller in participants with small
ARD than in those with normal or large ARD (both P<0.0001).
Consequently, carotid relative wall thickness was progres-
sively lower from small to large ARD (P<0.0001).
Antihypertensive therapy was not different among the 3
groups, with similar proportions of patients taking diuretics,
Ca++-channel blockers, and beta blockers, but a signiﬁcant
difference was noted in anti–renin-angiotensin system medica-
tions (anti-RAS, namely, angiotensin-converting enzyme inhibi-
tors or angiotensin receptor blockers), which were taken more
frequently in the subgroup with small ARD (21%) compared with
the groups with normal ARD (17%) or large ARD (15%, P<0.001).
Stroke volume was progressively greater from small to
large ARD (P<0.0001), paralleling trends in increasing heart
rate (P<0.01) and cuff diastolic BP (Table 2) and decreasing
PP (both P<0.0001), whereas systolic BP was similar among
the 3 ARD groups. The applanation tonometry estimates of
systolic, diastolic, and pulse central BP exhibited the same
distributions as the cuff BP (Table 2). It should be noted that
small ARD accommodates lower stroke volume but maintains
the same systolic BP as large ARD. Estimated arterial
compliance by the stroke volume/PP ratio was progressively
lower as the ARD decreased (P<0.0001).
Multivariable analysis was implemented on the basis of the
exploratory statistics, thus ARD-z variability was initially
tested using the 4 hemodynamic components at the basis
of our hypothesis (model 1) (Table 3). Eventually, all other
potential confounders, including body fatness and markers of
inﬂammation, were forced (model 2) (Table 3). ARD-z was
related positively to stroke volume, cuff diastolic BP, and
heart rate and negatively to cuff PP (model 1, all P<0.0001).
We also ran the same model using raw values of ARD
normalized for height and adjusting for sex, age, and degree of
relatedness. The relationship between ARD and hemodynamic
components was almost identical to that reported in Table 3
(b-coefﬁcients were 0.21 for stroke volume, 0.08 for PP,
0.08 for diastolic BP, and 0.06 for heart rate, all P<0.0001).
The addition of the correlates identiﬁed in exploratory
statistics (Table 1) did not modify the impact of the 4 primary
covariates but added some information (model 2). In partic-
ular, large ARD was independently correlated to waist
circumference (P<0.01), which blunted the effect of body
composition components detected in univariate analysis. As
expected, there was a moderately higher level of multi-
collinearity among waist circumference, fat-free mass, and
adipose mass but well below the level considered acceptable.
In addition, ARD was positively correlated with the percentage
of neutrophils of the white blood cell count and with the
circulating level of plasminogen activator inhibitor-1, whereas
no relations were detected with lipid proﬁle. Carotid intima–
media thickness, added to model 2, did not exhibit any
relationship with ARD (P=0.963). Finally, anti-RAS medica-
tions were not independently related to ARD-z (P=0.1), and
forcing them into the model did not change the coefﬁcients or
the signiﬁcance of covariates as shown in Table 3.
The same models as those in Table 3 were also run by
changing cuff BP to estimates of central BP (Table 4) for
participants in whom applanation tonometry was available.
Using central instead of cuff BP did not change the proﬁle of
the explained variance of ARD displayed in Table 3, except for
heart rate, which decreased its impact to a level that was no
longer signiﬁcant (P=0.4).
Other multivariable models were run using systolic BP
(either cuff or central) instead of PP. The relationship of ARD
to the covariates was conﬁrmed by regression also using
systolic BP (data not shown).
Discussion
In our analysis, we identiﬁed potential reasons for inconsistent
ﬁndings in the literature about relationships between arterial
Figure. Distribution of z score of aortic root dimension. The
straight continuous vertical line represents the mean, and the
dotted lines represent 1 SD.
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hypertension and ARD. Whether ARD was related to BP values
and how much other factors could interfere with this relation-
ship were explored only marginally in previous large population-
based studies6 and never using central BP. We demonstrated
that there are hemodynamic components strictly related to
ARD that need to be considered as a whole to understand those
relationships. We also demonstrated that other components of
the variability of ARD did not interfere with the relationship of
ARD to the hemodynamic components that we hypothesized to
be primary physiological determinants of variability of ARD. An
interesting parallelism has also been documented between
ARD and carotid diastolic dimension.
Consequently, after controlling for the confounding inﬂu-
ence of sex, age, and body size, ARD was inﬂuenced primarily
by the distending pressure stretching the aortic wall when the
aortic valve is closed and by the impact of the amount of
blood expelled on each heart beat. The frequency of cardiac
contraction also exhibited some inﬂuence, but the statistical
effect was substantially diluted when other cofactors were
considered, especially when BP was measured by applanation
tonometry. In the scenario presented in our analysis, diastolic
BP might be considered a determinant of ARD, and hyper-
tensive persons with uncontrolled diastolic BP should be
considered at risk of AR dilatation. In contrast, the compar-
ison of the results of exploratory statistics with those of
multivariable analysis indicated that PP decreased for larger
ARD at a given diastolic BP, stroke volume, and heart rate,
suggesting that small ARD might be a condition predisposing
to systolic hypertension by reducing the capacitance of the
proximal aorta.
Although the Framingham Heart Study already demon-
strated directionally opposite relationships of ARD diastolic/
Table 1. General Characteristics of Patients With Small, Normal, and Large ARD Based on Deviation From Predicted Values (z
score)
Small ARD
(n=1007)
Normal ARD
(n=1131)
Large ARD
(n=1022) Whole Cohort
Age, y 44.817.4*† 40.315.3 40.814.2 41.515.9
Sex (% women) 59.4 63.9 60.5 61.3
Aortic root, cm 3.080.22 3.310.27 3.630.32 3.340.35
Aortic root/height, cm/m 1.850.12*† 1.980.12 2.260.16 2.000.19
Hypertension, % 36.3 34.5 35.0 35.4
Diabetes, % 23.6 24.0 23.9 24.0
Obesity, % 47.8 * 59.5 69.9 58.7
Smokers—former smokers, % 34 – 26 36 – 23 39 – 26 36 – 25
BMI, kg/m2 30.46.9*† 32.87.5† 34.68.0 32.67.68
Waist girth, cm 100.816.4*† 106.117.9† 110.018.4 105.718.0
Fat-free mass, kg 53.711.7*† 54.912.3† 58.413.7 55.712.7
Adipose mass, kg 31.014.1*† 36.215.8† 39.316.7 35.615.9
C-reactive protein, mg/L 3.62 (1.64 to 8.33)*† 4.53 (2.07 to 9.2) 4.41 (1.91 to 9.36) 4.27 (1.86 to 8.87)
Fibrinogen, mg/dL 386.286.6† 394.688.2 394.994.4 392.2290.03
PAI-1, mg/dL 43.0 (25.0 to 65.0)*† 51.0 (30.0 to 80.0)† 54.0 (32.0 to 82.0) 49.0 (29.0 to 76.0)
White blood cell count, 109/L 6.961.86*† 7.241.94 7.262.05 7.151.96
Neutrophils, %* 59.38.7† 59.78.6† 60.88.4 59.978.63
Hematocrit, % 42.64.8 42.14.8 42.44.8 42.354.82
Fasting glucose, mg/dL 114.351.7 115.353.2 116.053.2 115.2752.80
Cholesterol, mg/dL 184.134.2 179.633.8† 185.334.4 182.7634.20
Triglycerides, mg/dL 160.491.0 159.587.6 167.594.0 162.2890.70
Carotid intima–media thickness, mm 0.690.17*† 0.660.16 0.670.15 0.670.16
Carotid diastolic diameter, mm 5.720.67† 5.790.63† 6.000.66 5.840.66
Carotid relative wall thickness 0.240.06*† 0.230.05† 0.220.05 0.230.05
ARD indicates aortic root dimension; BMI, body mass index; PAI-1, plasminogen activator inhibitor-1.
*0.05<P<0.0001 vs normal ARD.
†0.05<P<0.0001 vs large ARD.
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Table 2. Physiological Correlates of ARD
Small ARD
(n=1007)
Normal ARD
(n=1131)
Large ARD
(n=1022) Whole Cohort
Stroke volume, mL/beat 75.011.7*† 78.711.5† 82.212.8 78.6212.33
Cuff systolic BP, mm Hg 123.718.6 122.716.3 123.716.5 123.4217.23
Cuff diastolic BP, mm Hg 75.210.7*† 76.911.1† 79.110.9 77.0811.02
Cuff pulse pressure, mm Hg 48.517.1*† 45.813.2† 44.513.6 46.314.9
Stroke volume/pulse pressure, mL/mm Hg 1.710.60*† 1.840.55† 1.990.61 1.850.60
Heart rate, bpm 66.410.9† 67.210.5 67.910.8 67.2210.75
(n=756) (n=763) (n=800)
Central systolic BP, mm Hg 113.718.4 112.617.4 113.416.8 113.1817.51
Central diastolic BP, mm Hg 76.410.5*† 77.710.9† 79.211.0 77.8010.87
Central pulse pressure, mm Hg 37.314.9*† 34.912.7 34.112.7 35.3813.51
Stroke volume/pulse pressure, mL/mm Hg 2.320.94*† 2.560.98† 2.710.97 2.530.98
ARD indicates aortic root dimension; BP, blood pressure; bmp, beats per minute.
*0.005<P<0.0001 vs normal ARD.
†0.05<P<0.0001 vs large ARD.
Table 3. Models of Multiple Regression Analysis Testing the Variability of ARD-z Compared With Stroke Volume, Heart Rate,
Diastolic Blood Pressure and Pulse Pressure
Model 1
(Multiple R=0.35)
Model 2
(Multiple R=0.38)
Standardized
Coefﬁcients
b P Value
Variance
Inﬂation Factor
Standardized Coefﬁcients
b P Value
Variance
Inﬂation Factor
Age, y 0.07 <0.0006 1.37 0.10 <0.0001 1.69
Female sex 0.14 <0.0001 1.20 0.10 <0.009 4.01
Stroke volume, mL/beat 0.31 <0.0001 1.22 0.25 <0.0001 1.58
Cuff pulse pressure, mm Hg 0.11 <0.0001 1.37 0.10 <0.0001 1.38
Cuff diastolic BP, mm Hg 0.10 <0.0001 1.16 0.09 <0.0001 1.25
Heart rate, bpm 0.08 <0.0001 1.07 0.04 <0.02 1.17
Degree of relatedness* 0.05 <0.0513 1.75 0.05 <0.03 1.77
Body fat, kg — — — 0.01 <0.79 6.21
Fat-free mass, kg — — — 0.01 <0.79 5.01
Waist circumference, cm — — — 0.12 <0.01 6.60
White blood cell count, 109/L — — — 0.03 <0.23 1.35
Neutrophils, % — — — 0.07 <0.001 1.24
C-reactive protein, mg/L — — — 0.01 <0.58 1.46
Plasma fibrinogen, mg/dL — — — 0.03 <0.18 1.77
PAI-1, ng/mL — — — 0.05 <0.01 1.24
Triglycerides, mg/dL — — — 0.03 <0.17 1.32
Total cholesterol, mg/dL — — — 0.02 <0.31 1.37
In Model 1, the 4 hemodynamic components were entered; in Model 2, parameters of body fatness and inﬂammation were forced. ARD-z indicates sex-speciﬁc z score for measured and
predicted aortic root dimension values; BP, blood pressure; PAI-1, plasminogen activator inhibitor-1.
*Relatedness was evaluated by standard kinship coefﬁcients (0.25 for parent/offspring, 0.25 for full siblings, 0.125 for half siblings, and 0 for no consanguinity).29
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mean BP (positive) and systolic/pulse BP (negative), stroke
volume and other biologic correlates were not examined, and
the BP used in the analysis was taken peripherally with
sphygmomanometers. We extended those ﬁndings and doc-
umented, for the ﬁrst time, that the scenario identiﬁed using
cuff BP could be fully conﬁrmed using central BP estimates
and was not affected by other potential inﬂuences.
Our results and interpretations of our ﬁndings are consis-
tent with another more recent longitudinal analysis from the
Framingham Heart Study10 showing that longitudinal increase
in AR size was related to a corresponding decrease in PP.
What is missing in all previous reports on ARD is the
consideration of the stroke volume ejected into the aorta on
each heart beat. Integration of the force imposing the steady
tension on the AR, the stroke volume ejected that produces
phasic aortic strain, and the frequency of these pulsatile
deformations makes possible a better understanding of the
relationship with systolic BP and PP.
The present study also identiﬁed a relationship between
waist circumference and ARD that is independent of the 4
main hemodynamic correlates, a relationship that is also
unaffected by inﬂuences of age, sex, and height. Central fat
distribution is thus another important correlate of ARD and, in
the multivariable analysis, obscures the relationship identiﬁed
with body composition in the exploratory univariate analyses.
Central fat distribution has been reported to be associated
with elevated levels of circulating inﬂammatory markers.31,32
There are many conditions in which a high inﬂammatory state
has been reported to be associated with AR dilatation,33,34
thus the correlation between ARD and markers of inﬂamma-
tion, such as neutrophil percentage in the present study, was
not a surprise.35 Our understanding of the role of the
neutrophil in inﬂammation has changed fundamentally in
recent years. Despite the traditional interpretation of neu-
trophils as pure markers of immune response to external
factors, it is now recognized that activated neutrophils are
similar to macrophages and produce a number of inﬂamma-
tory cytokines, proteases, and chemoattractants36 that might
play important roles in the process of arteriosclerosis and
aortic dilatation.
The relationship of ARD with plasminogen activator
inhibitor-1 is also a new ﬁnding of our analysis. In addition
Table 4. Models of Multiple Regression Analysis Testing the Variability of ARD-z Compared With Stroke Volume, Heart Rate,
Central Diastolic Blood Pressure and Central Pulse Pressure Estimated by Applanation Tonometry
Model 1
(Multiple R=0.35)
Model 2
(Multiple R=0.38)
Standardized
Coefﬁcients
b P Value
Variance
Inﬂation
Factor
Standardized
Coefﬁcients
b P Value
Variance
Inﬂation
Factor
Age, y 0.08 <0.002 1.53 0.11 <0.0002 1.87
Female sex 0.15 <0.0001 1.18 0.11 <0.009 3.98
Stroke volume, mL/beat 0.31 <0.0001 1.23 0.25 <0.0001 1.56
Central pulse pressure, mm Hg 0.09 <0.001 1.64 0.09 <0.0009 1.66
Central diastolic BP, mm Hg 0.10 <0.0001 1.11 0.08 <0.0004 1.19
Heart rate, bpm 0.05 <0.02 1.09 0.02 <0.40 1.18
Degree of relatedness* 0.03 <0.30 1.65 0.03 <0.21 1.68
Body fat, kg — — — 0.01 <0.85 5.59
Fat-free mass, kg — — — 0.02 <0.69 5.10
Waist circumference, cm — — — 0.13 <0.02 6.28
White blood cell count, 109/L — — — 0.02 <0.36 1.34
Neutrophils, % — — — 0.07 <0.003 1.24
C-reactive protein, mg/L — — — 0.01 <0.57 1.47
Plasma fibrinogen, mg/dL — — — 0.03 <0.2501 1.74
PAI-1, ng/mL — — — 0.05 <0.0353 1.24
Triglycerides, mg/dL — — — 0.03 <0.1786 1.31
Total cholesterol, mg/dL — — — 0.02 <0.4864 1.32
In Model 1, the 4 hemodynamic components were entered; in Model 2, parameters of body fatness and inﬂammation were forced. ARD-z indicates sex-speciﬁc z score for measured and
predicted aortic root dimension values; BP, blood pressure; PAI-1, plasminogen activator inhibitor-1.
*Relatedness was evaluated by standard kinship coefﬁcients (0.25 for parent/offspring, 0.25 for full siblings, 0.125 for half siblings, and 0 for no consanguinity).29
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to its activity on ﬁbrinolysis, plasminogen activator inhibitor-1
regulates circulating levels of a number of inﬂammatory
cytokines, such as tumor necrosis factor-a, interleukin-6, and
interferon-c,37 and might also be overexpressed as a conse-
quence of the upregulation of proinﬂammatory cytokines
(overproduced by visceral fat). Endothelium dysfunction, a
consequence of the latent inﬂammatory status in visceral
obesity, increases secretion of a number of endothelial
products such as plasminogen activator inhibitor-1,38 gener-
ating a vicious cycle. Experimental studies and human
conditions strongly suggest that inﬂammation is a concurrent
cause of aortic dilatation.39,40
Our ﬁndings need to be interpreted taking into account the
cross-sectional nature of this study, which does not allow any
cause–effect inference; however, it is interesting that despite
the interference of a number of physiological and pathological
confounders, a close correlation remains between ARD and
the key hemodynamic parameters studied in this analysis. The
equation tested in this analysis was derived from a multieth-
nic population but was applied to a speciﬁc ethnicity, a
potential mismatch that should be taken into account when
interpreting our results; however, the equation has already
been validated in different populations.22
In addition, despite the good reliability tested in our
echocardiography laboratory,23 the limitations inherent to
ultrasound evaluation of CV structures (signal noise, acoustic
artifacts) should always be considered when interpreting
these data. In our analysis, the impact of these potential
technical pitfalls is at least partially limited by the large
number of observations, which dilutes the error.41
Finally, in evaluating the results obtained with central
pressure, one needs to take into account that the calibration
of the radial waveforms was done using brachial diastolic and
systolic pressure, thus neglecting the possible ampliﬁcation
from brachial to radial site, with the possibility of a slight
underestimation of calculated central pressure.42,43
Perspectives
We used a novel approach to evaluate deviations of ARD from
what would be appropriate for a given age, sex, and height,
and that allowed us to identify a number of characteristics
related to either small or large AR. This approach might be
used in clinical practice to identify patients with AR dilatation
and in longitudinal study to establish risk. Our ﬁndings also
raise questions concerning the evolution of AR dilatation in
hypertensive populations, based on hemodynamic character-
istics of high blood pressure and the potential importance of
the native AR in the progression toward isolated systolic
hypertension. Further research needs to explore these
aspects and possibly clarify whether ﬁndings at the level of
the Valsalva sinuses may be extended to thoracic and
abdominal aorta, as ﬁndings on carotid geometry might
suggest.
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